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Since the development of the ruby 
laser by Maiman in 1959, two major 
questions have been raised with regard 
to ophthalmology: 
1. What is the feasibility for its 
clinical use as a therapeutic device? 
2. What are the hazards of acci-
dental exposures among personnel 
working with lasers in industry, re-
search, and military installations; 
how to counteract them? 
After clinical light coagulation for 
various ocular lesions had been in-
cluded in the therapeutic armamen-
tarium, the introduction of the laser 
for similar purposes was obvious, and 
has been accepted with enthusiasm by 
various groups of clinical investiga-
tors. Since, at present, the ruby laser 
is only used for ophthalmological pur-
poses, the basic principles of its action 
are briefly reviewed. 
Fundamentals of Laser Action 
When a photon is absorbed by an 
atom, the energy of the photon is 
converted to internal energy of the 
atom. The atom is then raised to an 
"excited" quantum state. Later it may 
radiate this energy spontaneously, 
emitting a photon and reverting to the 
ground state or to some state in be-
tween. 
In such an excited state the atom 
can be stimulated to emit a photon, if 
it is struck by another photon having 
precisely the energy of the one that 
would otherwise be emitted spontane-
ously. As a result, the incoming pho-
ton, or wave, is augmented by the one 
given up by the excited atom. More 
important, the wave, upon release, 
falls precisely in phase with the wave 
that triggered its release. There must 
be an excess of excited atoms to en-
able stimulated emission to predomi-
nate over absorption. 
In the ruby laser (aluminum oxide 
poisoned with a few chromium atoms 
-Maiman used .05% by wt of chro-
mium), light in the green and yellow 
bands is absorbed, while blue and red 
are allowed to pass through. The ab-
sorbed light raises the chromium atoms 
to the excited state from which two 
steps are required to carry them back 
to the ground state. 
First, they give up some of their 
energy to the crystal lattice and land 
temporarily in a metastable state. If 
not subjected to stimulation, their stay 
at this level lasts a few msec while 
they drop at random to the ground 
state. 
Photons emitted during this final 
drop have a wavelength of 6,943 A 
(at room temperature). In the laser, 
however, the first few photons re-
leased stimulate the still excited chro-
mium atoms to give· up photons and 
return to the ground state much faster. 
If a great number of atoms are ex-
cited, the ruby merely emits a burst 
of its typical red fluorescence, spread 
over the usual decay period for the 
excited atoms. But above a critical 
level, in which more than 50% of the 
total atoms are brought in the excited 
state, the atoms return to the ground 
state at the very same moment. They 
last approximately 200 to 500 µsec, 
during which time an intense mono-
chromatic light beam flashes from the 
laser crystal. The beam is almost par-
allel if produced at threshold levels. 
With greater energies increasing di-
vergence occurs. 
From the foregoing it becomes ob-
vious that the characteristics of laser 
radiation are different in several as-
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pects from the clinical light coagulator 
used before. The most important dif-
ferences are: 
1) The spectral distribution of the 
light source, and 
2) The exposure time for produc-
tion of chorioretinal "burns." 
While the conventional Zeiss light 
coagulator utilizes a xenon high pres-
sure lamp with a spectral range 
throughout the visible spectrum, the 
ruby laser beam is monochromatic and 
produces light at a wavelength of 
6,943 A only. Moreover, the light co-
agulator allows the ophthalmologist to 
control the exposure time by pressing 
a button situated on the ophthalmo-
scope handle; thus the exposure time 
is determined under direct vision of 
the developing tissue response. On the 
other hand, the exposure time with the 
use of the laser is inherent within the 
instrument, and is not controllable 
during the exposure. Thus, while the 
light coagulator exposures usually 
range from about 0.1 sec to 1 sec, ruby 
laser exposure times are in the neigh-
borhood of 500 µ,sec . 
These two factors-wavelength and 
exposure time-however, are of fun-
damental importance with regard to 
tissue reaction. During recent years 
absorption characteristics of the hu-
man and the rabbit eye have been 
studied, especially with respect to ab-
sorption distribution in the pigmented 
layers of the ocular fundus. The data 
were compared with reflection meas-
urements from the ocular fundus, and 
with light energies required to produce 
ophthalmoscopic visible minimal le-
sions. Moreover, the influence of blood 
flow on the development of ocular 
thermal effect has been investigated. 
More recently, a histological and his-
tochemical comparison of ocular le-
sions produced with light coagulation 
with those produced with a ruby laser 
has been described. In later studies 
exposure times for light coagulation 
were 30 msec and 175 µ,sec, while 
laser exposures were achieved with 
200 µ,sec for "pulsed" and 30 µ,sec . 
for "q-switched" laser action (Geeraets" 
et al., 1960, 1962a and b, 1963, and 
1965; Ham et al., 1963). 
Clinical Considerations 
Initial Promise and Present Limitations 
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The Zeiss light coagulator has been 
used for over a decade to treat such 
ocular lesions as retinal detachment, 
vascular lesions of the retina and 
choroid, inflammatory chorioretinal 
conditions, iris lesions, etc. As soon as 
the laser was introduced, several of its 
features seemed more advantageous 
relative to this conventional light co-
agulator: 
1) The price of the instrument was 
expected to be considerably lower than 
that of the Zeiss light coagulator. 
2) The instrument promised to be 
quite light so that it could easily be 
carried to the patient's bedside, instead 
of having to bring the patient to the 
instrument. 
3) The very short exposure times 
wae regarded as beneficial, since with 
these exposure times the patient would 
not be able to move his eye, thus elimi-
nating the need for retrobulbar anes-
thesia. 
4) The dim red light of the laser 
beam (A. = 6,943 A) will not produce 
photophobia, another reason for elimi-
nating anesthesia. 
5) The short-time, high-intensity ex-
posures would allow much smaller le-
sions than those produced by light co-
agulation. 
However, after several years of 
clinical and laboratory experimenta-
tion, these anticipated advantages ap-
pear at present not as obvious or as 
convincing as a number of investiga-
tors had initially expected. Moreover, 
it is quite certain today that the laser 
has not broadened clinical indications 
nor has it opened new fields for thera-
peutic application of high intensity 
light. 
Several instruments utilizing the 
pulsed ruby laser are now commer-
cially available. With the desire to de-
velop a therapeutic device having as 
many safeguards as possible against 
possible overexposures, the price and 
weight of the instruments have both in-
creased and are still rising; thus the ex-
pected advantages outlined above 
under 1) and 2) seem not to be war-
ranted. It is true, however, that the 
short exposure time and the dim red 
light do not necessitate retrobulbar 
anesthesia of the patient's eye. This 
minor advantage is contradicted by the 
dangers of short-time exposures. When 
the instrument is triggered, the degree 
and severity of the chorioretinal lesion 
is decided upon. Even if the surgeon 
has followed instructions and started 
with low instrument settings-Le., low 
energy output which does not cause 
any lesions-and has slowly increased 
the laser beam intensity, the exposures 
are not without danger. The energy 
output of the laser varies from shot to 
shot in a random fashion unless special 
precautions are taken. Moreover, the 
energy control settings of the instru-
ments have only a very small range 
between therapeutically desirable in-
tensities, and those which will produce 
severe overexposures. With this nar-
row range, and the possible fluctua-
tions from one exposure to another, 
the usefulness of the instruments pres-
ently available is limited. Beside these 
inherent limitations, the irregularities 
in pigment distribution of the ocular 
fundus add to the potential hazards 
which might be encountered. Exami-
nation of a number of eyes treated 
elsewhere with lasers, for various etio-
logical reasons, revealed lesions which 
were too severe and well above opti-
mal therapeutic levels. Many of the 
lesions showed centrally located reti-
nal holes with small hemorrhages and 
pigment clumps extending into the 
vitreous. 
There may be an advantage in pro-
ducing chorioretinal coagulations with 
very short exposure times when the 
exposure has to be made in a region 
where injury to the nerve fiber layer 
may result in a large scotoma. Here, 
the short exposure times allow for the 
coagulation effect to be restricted to 
the choroid and outer retinal layers, 
thus sparing the inner layers of the 
retina and the nerve fibers passing 
over the lesion. This observation, made 
in numerous experiments (Geeraets, 
Burkhart, and Guerry, 1963), can be 
explained by the absence of tissue 
damage due to thermal conduction 
during actual exposure time, if the ex-
posure times are sufficiently short, i.e., 
in µ,sec . The lesions thus produced 
must be very mild as heat conduction, 
continuing from the site of coagulation 
after the exposure has terminated, 
might be sufficient to cause coagula-
tion of all retinal layers. 
The statement that smaller retinal 
lesions can be produced with a laser is 
true, but is of little clinical impor-
tance. I have never observed a clinical 
situation in which a lesion smaller 
than that producible with the common 
light coagulator was desired. 
Use in Retinal Tumors 
Retinal tumors have been men-
tioned as another indication for laser 
treatment. Here, too, the same rules 
can be applied that have been estab-
lished for treatment of tumors with 
light coagulation. One might even 
speculate that the more extensive co-
agulation effect using common light 
coagulation techniques may be more 
destructive to tumor cells than the 
laser beam. But the very restricted in-
dications for coagulation treatment of 
ocular neoplasm remains the same for 
both methods. 
Experimental data obtained on tu-
mor transplants within the supracho-
roidal space have shown some of the 
restrictions one has to observe in such 
attempts of treatment (Geeraets, 
Ghosh, and Guerry, 1962; Chan et al., 
1963). In cases of retinal angiomata, 
the red light of the ruby is reflected 
to a great extent, thus unnecessarily 
increasing the incident total light 
energy applied to the ocular media 
and other ocular structures. 
Accidental Laser Exposures 
With the very powerful devices de-
veloped for industrial, military, and 
research use, accidental exposures of 
the human retina have presented a 
true hazard. Not only the direct expo-
sure to the laser beam, but also laser 
light from any reflecting surface may 
result in permanent ocular injury. 
Since light of the ruby laser (.\. = 
6,943 A) is dim red, and light from 
the neodymium laser (.\. = 1,060 A) is 
completely outside the visible spec-
trum, the potential hazard to the eye 
is greatly enhanced as no immediate 
discomfort is experienced by the vic-
tim. If the ocular lesion is mild and 
located in the peripher)' of the retina, 
the victim may not even be aware of 
the accident. I have seen such lesions 
on routine examination where there 
was no doubt as to the etiology of the 
lesion. If exposures occur to the fovea 
or macular area, as in cases where the 
patient is "fixing" the laser source 
WALTER J. GEERAETS 
along the axis of the laser beam or a 
reflecting spot, the lesion may be of 
serious consequence, even with mild 
retinal lesions. And if both eyes are 
involved, which most likely will hap-
pen if the patient is "fixing" on the 
bright light, the developing macular 
lesions may produce permanent visual 
loss. 
In case of high-intensity exposures, 
for instance, as with the giant pulse 
laser, central as well as peripheral 
fundus lesions may lead to an explo-
sion-like disruption of the retina and 
choroid, with massive hemorrhages 
into the vitreous, resulting in perma-
nent loss of one or both eyes. 
These accidental possibilities have 
necessitated extensive precautions in 
most installations and laboratories 
where laser devices are used. Warning 
signs have been placed in most loca-
tions during actual laser operation. 
Laboratory facilities and equipment 
have been painted with dark and dull 
colors to reduce reflection. Special 
goggles with hardened lenses and color 
filters have been developed for eye 
protection. But in spite of these pre-
cautions, accidental exposures are not 
infrequent. Bright flashes of white 
light produce photophobia and hence 
constantly bring the danger of expo-
sure to the persons working with these 
light sources. With the dark red laser 
beam or the invisible neodymium 
beam this reminder is absent, possibly 
explaining the observed negligence by 
laboratory personnel involved. For 
legal reasons it has been recommended 
that any prospective employee to work 
with, or in the vicinity of, laser de-
vices be given a very thorough eye 
examination by a qualified ophthal-
mologist to record all possible existing 
fundus pathology or anomalies before 
the person begins work. Routine fol-
low-up examinations should be per-
formed within reasonable periods to 
insure that no accidental fundus ex-
posures have occurred without the 
person's knowledge. All reported pos-
sible exposures should get immediate 
medical attention, since laser lesions 
are more accurately determined the 
sooner they are examined after expo-
sure. After longer periods of time, scar 
formation may not be differentiated 
from other preexisting inflammatory 
lesions. 
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According to Tebrock, Young, and 
Machle (1963), the principles of con-
trolling environmental laser hazards 
are: 
1) Avoidance of the principal beam 
and its reflections. 
2) Proper education of personnel 
involved. 
3) General information given those 
who might be casually exposed. 
4) Use of warning devices to indi-
cate laser is in operation. 
5) Policing and clearing of area for 
long range operation. 
6) Use of proper antilaser eye 
shields on any observer likely to be 
exposed. 
7) Use of count-downs with per-
sons closing eyes or looking away 
from pulsed, high-power beam. 
8) Reporting of all persistent after-
images to medical department. 
9) Funduscopic and slit-lamp ex-
amination of all people involved in 
laser operations. 
Conclusions 
In spite of the limitations and po-
tential hazards involved in ophthalmic 
application of laser energy at its pres-
ent status of development, further 
clinical investigation is necessary. It 
should be restricted to a few centers, 
experienced in this type of work, and 
aware of the fundamental physical and 
biological mechanisms involved. In 
reality, this practice is not always fol-
lowed, thus increasing the potential 
danger of the clinical use of lasers. 
Although some of the available in-
struments are beautifully designed and 
engineered, these attributes alone do 
not justify their therapeutic use. In my 
opinion, arrangements to make the 
present existing laser coagulators com-
mercially available to all clinical oph-
thalmologists are irresponsible, to say 
the least. Some of the ophthalmolo-
gists are misled by erroneous adver-
tisement and receive their instruction 
from overzealous sales personnel lack-
ing adequate knowledge of the phys-
ical principles of laser, or of the 
biological, optical, and functional 
characteristics of the eye. 
Summary 
The present status of laser appli-
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cation in clinical ophthalmology is 
discussed. The differences between 
conventional light coagulator charac-
teristics and those of presently avail-
able ruby lasers for clinical use are 
compared. The limitations and haz-
ards of laser therapy are stressed. 
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